Restates Position that Pacira's Board Should Conduct Formal Sales Process of the Business Considers Current Executive Compensation and Spending Exorbitant and Unmerited Questions Whether the Board Has Exercised Appropriate Fiduciary Oversight MIAMI, Dec. 30, 2025 /PRNewswire/ -- DOMA...
DOMA Perpetual Capital Management Announces Intent to Nominate Three Highly Qualified, Independent Director Candidates at 2026 Annual Meeting of Pacira BioSciences, Inc.
